Targeting transforming growth factor-β signaling in liver metastasis of colon cancer

Bixiang Zhang, Sunil K. Halder, Sanguo Zhang, Pran K. Datta

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Despite a primary tumor suppressor role, there is compelling evidence suggesting that TGF-β can promote tumor growth, invasion and metastasis in advanced stages of colorectal cancer. Blocking these tumor-promoting effects of TGF-β provides a potentially important therapeutic strategy for the treatment of colorectal cancer. However, little is known about how the inhibitors of TGF-β receptor kinases affect colorectal carcinogenesis in vivo. Here, we have observed that a novel dual kinase inhibitor of TGF-β type I and type II receptors, LY2109761, inhibits TGF-β-mediated activation of Smad and non-Smad pathways in CT26 colon adenocarcinoma cells having K-Ras mutation. The inhibitor attenuates the oncogenic effects of TGF-β on cell migration, invasion and tumorigenicity of CT26 cells. Furthermore, LY2109761 decreases liver metastases and prolongs survival in an experimental metastasis model. These findings suggest that the dual kinase inhibitor LY2109761 has potential therapeutic value for metastatic colorectal cancer.

Original languageEnglish (US)
Pages (from-to)114-120
Number of pages7
JournalCancer Letters
Volume277
Issue number1
DOIs
StatePublished - May 8 2009

Fingerprint

Transforming Growth Factors
Colonic Neoplasms
Colorectal Neoplasms
Phosphotransferases
Neoplasm Metastasis
Liver
Neoplasms
Cell Movement
Colon
Carcinogenesis
Adenocarcinoma
Theoretical Models
Mutation
Therapeutics
Growth

Keywords

  • Bioluminescence
  • Colon cancer
  • LY2109761
  • Liver metastasis
  • TGF-β

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Targeting transforming growth factor-β signaling in liver metastasis of colon cancer. / Zhang, Bixiang; Halder, Sunil K.; Zhang, Sanguo; Datta, Pran K.

In: Cancer Letters, Vol. 277, No. 1, 08.05.2009, p. 114-120.

Research output: Contribution to journalArticle

Zhang, Bixiang ; Halder, Sunil K. ; Zhang, Sanguo ; Datta, Pran K. / Targeting transforming growth factor-β signaling in liver metastasis of colon cancer. In: Cancer Letters. 2009 ; Vol. 277, No. 1. pp. 114-120.
@article{c434921262dc424eae41492e9f602165,
title = "Targeting transforming growth factor-β signaling in liver metastasis of colon cancer",
abstract = "Despite a primary tumor suppressor role, there is compelling evidence suggesting that TGF-β can promote tumor growth, invasion and metastasis in advanced stages of colorectal cancer. Blocking these tumor-promoting effects of TGF-β provides a potentially important therapeutic strategy for the treatment of colorectal cancer. However, little is known about how the inhibitors of TGF-β receptor kinases affect colorectal carcinogenesis in vivo. Here, we have observed that a novel dual kinase inhibitor of TGF-β type I and type II receptors, LY2109761, inhibits TGF-β-mediated activation of Smad and non-Smad pathways in CT26 colon adenocarcinoma cells having K-Ras mutation. The inhibitor attenuates the oncogenic effects of TGF-β on cell migration, invasion and tumorigenicity of CT26 cells. Furthermore, LY2109761 decreases liver metastases and prolongs survival in an experimental metastasis model. These findings suggest that the dual kinase inhibitor LY2109761 has potential therapeutic value for metastatic colorectal cancer.",
keywords = "Bioluminescence, Colon cancer, LY2109761, Liver metastasis, TGF-β",
author = "Bixiang Zhang and Halder, {Sunil K.} and Sanguo Zhang and Datta, {Pran K.}",
year = "2009",
month = "5",
day = "8",
doi = "10.1016/j.canlet.2008.11.035",
language = "English (US)",
volume = "277",
pages = "114--120",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Targeting transforming growth factor-β signaling in liver metastasis of colon cancer

AU - Zhang, Bixiang

AU - Halder, Sunil K.

AU - Zhang, Sanguo

AU - Datta, Pran K.

PY - 2009/5/8

Y1 - 2009/5/8

N2 - Despite a primary tumor suppressor role, there is compelling evidence suggesting that TGF-β can promote tumor growth, invasion and metastasis in advanced stages of colorectal cancer. Blocking these tumor-promoting effects of TGF-β provides a potentially important therapeutic strategy for the treatment of colorectal cancer. However, little is known about how the inhibitors of TGF-β receptor kinases affect colorectal carcinogenesis in vivo. Here, we have observed that a novel dual kinase inhibitor of TGF-β type I and type II receptors, LY2109761, inhibits TGF-β-mediated activation of Smad and non-Smad pathways in CT26 colon adenocarcinoma cells having K-Ras mutation. The inhibitor attenuates the oncogenic effects of TGF-β on cell migration, invasion and tumorigenicity of CT26 cells. Furthermore, LY2109761 decreases liver metastases and prolongs survival in an experimental metastasis model. These findings suggest that the dual kinase inhibitor LY2109761 has potential therapeutic value for metastatic colorectal cancer.

AB - Despite a primary tumor suppressor role, there is compelling evidence suggesting that TGF-β can promote tumor growth, invasion and metastasis in advanced stages of colorectal cancer. Blocking these tumor-promoting effects of TGF-β provides a potentially important therapeutic strategy for the treatment of colorectal cancer. However, little is known about how the inhibitors of TGF-β receptor kinases affect colorectal carcinogenesis in vivo. Here, we have observed that a novel dual kinase inhibitor of TGF-β type I and type II receptors, LY2109761, inhibits TGF-β-mediated activation of Smad and non-Smad pathways in CT26 colon adenocarcinoma cells having K-Ras mutation. The inhibitor attenuates the oncogenic effects of TGF-β on cell migration, invasion and tumorigenicity of CT26 cells. Furthermore, LY2109761 decreases liver metastases and prolongs survival in an experimental metastasis model. These findings suggest that the dual kinase inhibitor LY2109761 has potential therapeutic value for metastatic colorectal cancer.

KW - Bioluminescence

KW - Colon cancer

KW - LY2109761

KW - Liver metastasis

KW - TGF-β

UR - http://www.scopus.com/inward/record.url?scp=61849183646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61849183646&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2008.11.035

DO - 10.1016/j.canlet.2008.11.035

M3 - Article

C2 - 19147275

AN - SCOPUS:61849183646

VL - 277

SP - 114

EP - 120

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 1

ER -